Methodological considerations in assessing GLP-1 receptor agonists and gastrointestinal cancer risk

Pharmacol Res. 2024 Oct 28:210:107481. doi: 10.1016/j.phrs.2024.107481. Online ahead of print.
No abstract available

Publication types

  • Letter